Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.32B | $59.77B | $59.38B | $57.79B | $54.30B | $46.88B | $52.33B | $53.04B | $54.86B | $45.52B | $43.06B |
| Gross profit | $33.18B | $33.02B | $31.98B | $31.48B | $31.21B | $27.25B | $31.97B | $33.11B | $33.88B | $27.71B | $26.47B |
| Research & development | — | — | — | — | $298.0M | $296.0M | $291.0M | $276.0M | $265.0M | $244.0M | $207.0M |
| Operating income | $15.40B | $15.49B | $13.97B | $14.52B | $13.82B | $9.62B | $16.10B | $16.41B | $16.46B | $12.88B | $13.90B |
| EBITDAderived | $21.06B | $21.03B | $19.38B | $19.59B | $18.88B | $14.45B | $20.75B | $21.04B | $21.09B | $16.36B | $17.06B |
| Net income | $6.84B | $5.86B | $5.34B | $5.97B | $4.67B | $1.41B | $9.17B | $4.37B | $7.99B | $1.24B | $8.27B |
| Basic EPSper diluted share | $3.45 | $2.92 | $2.65 | $2.97 | $2.33 | $0.70 | $4.62 | $2.21 | $4.05 | $0.72 | $5.05 |
| Diluted EPSper diluted share | $3.39 | $2.86 | $2.60 | $2.91 | $2.28 | $0.69 | $4.53 | $2.17 | $3.98 | $0.71 | $4.96 |